Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum

Abstract Background Colostrum is the primary source of maternal immunoglobulin A (IgA) for the newborn. IgA participates in protection and regulation mechanisms of the immune response at the neonate’s mucosa. Several studies have evaluated infectious diseases and vaccine protocols effects during pre...

Full description

Bibliographic Details
Main Authors: Erick Sánchez-Salguero, Geovanni Kaleb Mondragón-Ramírez, Julio C. Alcántara-Montiel, Arturo Cérbulo-Vázquez, Xóchitl Villegas-Domínguez, Víctor Manuel Contreras-Vargas, María del Rocío Thompson-Bonilla, Héctor Romero-Ramírez, Leopoldo Santos-Argumedo
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Maternal Health, Neonatology and Perinatology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40748-019-0104-x
_version_ 1818232264731918336
author Erick Sánchez-Salguero
Geovanni Kaleb Mondragón-Ramírez
Julio C. Alcántara-Montiel
Arturo Cérbulo-Vázquez
Xóchitl Villegas-Domínguez
Víctor Manuel Contreras-Vargas
María del Rocío Thompson-Bonilla
Héctor Romero-Ramírez
Leopoldo Santos-Argumedo
author_facet Erick Sánchez-Salguero
Geovanni Kaleb Mondragón-Ramírez
Julio C. Alcántara-Montiel
Arturo Cérbulo-Vázquez
Xóchitl Villegas-Domínguez
Víctor Manuel Contreras-Vargas
María del Rocío Thompson-Bonilla
Héctor Romero-Ramírez
Leopoldo Santos-Argumedo
author_sort Erick Sánchez-Salguero
collection DOAJ
description Abstract Background Colostrum is the primary source of maternal immunoglobulin A (IgA) for the newborn. IgA participates in protection and regulation mechanisms of the immune response at the neonate’s mucosa. Several studies have evaluated infectious diseases and vaccine protocols effects during pregnancy on maternal milk IgA levels, with the aim to understand lactation protecting effect on newborn. However, most of their results demonstrated that there were no differences in the total IgA levels. In humans, IgA has two subclasses (IgA1 and IgA2), they have an anatomical distribution among mucosal compartments, their levels vary after antigen stimulation and are also seen to describe differential affinities in colostrum. Although there are differences between IgA subclasses in several compartments, these studies have excluded specific colostrum IgA1 and IgA2 determination. Methods We analyzed data from 900 women in Mexico City. With Pearson correlation, we compared the number of infectious episodes during their pregnancy that was associated with mucosal compartments (skin, respiratory and gastrointestinal tracts) and colostrum IgA subclasses. Results We show a correlation between increased colostrum IgA1 levels and the number of infectious episodes at respiratory tract and the skin. In contrast, infections at the gastrointestinal tract correlated with increased IgA2 amounts. Conclusions Infections present during pregnancy at certain mucosal site increase specific IgA subclasses levels in human colostrum. These results will help in understanding infections and immunizations effects on maternal IgA at the mammary gland, and their impact on the development and protection of the newborn.
first_indexed 2024-12-12T11:03:32Z
format Article
id doaj.art-e03f3e5f92eb474381176ed48e72d879
institution Directory Open Access Journal
issn 2054-958X
language English
last_indexed 2024-12-12T11:03:32Z
publishDate 2019-06-01
publisher BMC
record_format Article
series Maternal Health, Neonatology and Perinatology
spelling doaj.art-e03f3e5f92eb474381176ed48e72d8792022-12-22T00:26:29ZengBMCMaternal Health, Neonatology and Perinatology2054-958X2019-06-01511810.1186/s40748-019-0104-xInfectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrumErick Sánchez-Salguero0Geovanni Kaleb Mondragón-Ramírez1Julio C. Alcántara-Montiel2Arturo Cérbulo-Vázquez3Xóchitl Villegas-Domínguez4Víctor Manuel Contreras-Vargas5María del Rocío Thompson-Bonilla6Héctor Romero-Ramírez7Leopoldo Santos-Argumedo8Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), National Polytechnic Institute (IPN)Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), National Polytechnic Institute (IPN)School of Higher Studies Zaragoza, National Autonomous University of Mexico (UNAM), Regional Hospital of High Specialty of Ixtapaluca (HRAEI)Faculty of Medicine, Plan of Combined Studies in Medicine (PECEM), National Autonomous University of Mexico (UNAM)Women’s Hospital, Ministry of Health (SSA)Departments of Gynecology and Genomic Medicine, Regional Hospital 1° de Octubre, Institute of Security and Social Services of State Workers (ISSSTE)Departments of Gynecology and Genomic Medicine, Regional Hospital 1° de Octubre, Institute of Security and Social Services of State Workers (ISSSTE)Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), National Polytechnic Institute (IPN)Department of Molecular Biomedicine, Center for Research and Advanced Studies (CINVESTAV), National Polytechnic Institute (IPN)Abstract Background Colostrum is the primary source of maternal immunoglobulin A (IgA) for the newborn. IgA participates in protection and regulation mechanisms of the immune response at the neonate’s mucosa. Several studies have evaluated infectious diseases and vaccine protocols effects during pregnancy on maternal milk IgA levels, with the aim to understand lactation protecting effect on newborn. However, most of their results demonstrated that there were no differences in the total IgA levels. In humans, IgA has two subclasses (IgA1 and IgA2), they have an anatomical distribution among mucosal compartments, their levels vary after antigen stimulation and are also seen to describe differential affinities in colostrum. Although there are differences between IgA subclasses in several compartments, these studies have excluded specific colostrum IgA1 and IgA2 determination. Methods We analyzed data from 900 women in Mexico City. With Pearson correlation, we compared the number of infectious episodes during their pregnancy that was associated with mucosal compartments (skin, respiratory and gastrointestinal tracts) and colostrum IgA subclasses. Results We show a correlation between increased colostrum IgA1 levels and the number of infectious episodes at respiratory tract and the skin. In contrast, infections at the gastrointestinal tract correlated with increased IgA2 amounts. Conclusions Infections present during pregnancy at certain mucosal site increase specific IgA subclasses levels in human colostrum. These results will help in understanding infections and immunizations effects on maternal IgA at the mammary gland, and their impact on the development and protection of the newborn.http://link.springer.com/article/10.1186/s40748-019-0104-xImmunoglobulin AIgA1IgA2Respiratory tractGastrointestinal tractColostrum
spellingShingle Erick Sánchez-Salguero
Geovanni Kaleb Mondragón-Ramírez
Julio C. Alcántara-Montiel
Arturo Cérbulo-Vázquez
Xóchitl Villegas-Domínguez
Víctor Manuel Contreras-Vargas
María del Rocío Thompson-Bonilla
Héctor Romero-Ramírez
Leopoldo Santos-Argumedo
Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
Maternal Health, Neonatology and Perinatology
Immunoglobulin A
IgA1
IgA2
Respiratory tract
Gastrointestinal tract
Colostrum
title Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
title_full Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
title_fullStr Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
title_full_unstemmed Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
title_short Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum
title_sort infectious episodes during pregnancy at particular mucosal sites increase specific iga1 or iga2 subtype levels in human colostrum
topic Immunoglobulin A
IgA1
IgA2
Respiratory tract
Gastrointestinal tract
Colostrum
url http://link.springer.com/article/10.1186/s40748-019-0104-x
work_keys_str_mv AT ericksanchezsalguero infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT geovannikalebmondragonramirez infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT juliocalcantaramontiel infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT arturocerbulovazquez infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT xochitlvillegasdominguez infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT victormanuelcontrerasvargas infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT mariadelrociothompsonbonilla infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT hectorromeroramirez infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum
AT leopoldosantosargumedo infectiousepisodesduringpregnancyatparticularmucosalsitesincreasespecificiga1origa2subtypelevelsinhumancolostrum